TgPRELID, a Mitochondrial Protein Linked to Multidrug Resistance in the Parasite Toxoplasma gondii

New drugs to control infection with the protozoan parasite Toxoplasma gondii are needed as current treatments exert toxic side effects on patients. Approaches to develop novel compounds for drug development include screening of compound libraries and targeted inhibition of essential cellular pathway...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeffers, Victoria, Kamau, Edwin T., Srinivasan, Ananth R., Harper, Jonathan, Sankaran, Preethi, Post, Sarah E., Varberg, Joseph M., Sullivan, William J., Boyle, Jon P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288566/
https://www.ncbi.nlm.nih.gov/pubmed/28168222
http://dx.doi.org/10.1128/mSphere.00229-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288566/
https://www.ncbi.nlm.nih.gov/pubmed/28168222
http://dx.doi.org/10.1128/mSphere.00229-16

Ejemplares similares